N/A Completed N=87 Randomized Single-blind Treatment

Greater Occipital and Supraorbital Nerve Blockade in Migraine Patients

Migraine Disorders

Source: ClinicalTrials.gov NCT03435185 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jul 2019

Primary outcomePrimary: Change of Frequency of Headache — 5.3; 7.5 score on a scale

Summary

The investigators aimed to evaluate the efficacy of greater occipital nerve and supraorbital nerve blockade with local anesthetics for the preventive treatment of migraine without aura.

Outcome Measures

Outcome	Result	p-value
PRIMARY Change of Frequency of Headache	5.3; 7.5	—
PRIMARY Change of Severity of Headache	5.5; 7.4	—

Eligibility Criteria

Inclusion Criteria

Lack of benefits 1 year from preventive treatment or intolerance to their treatments.
18 ≥ years old
Migraine without aura for more than 1 year, minimum of two or more migraine attacks per month.

Exclusion Criteria

Patients with any chronic illness, medication overuse headache, a history of cranial and cervical surgery
Allergies to local anesthetics
Hemorrhagic diathesis
Alcohol or drug abuse

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03435185). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.